LENZ Therapeutics, Inc. (LENZ)
4.13
-0.01
(-0.24%)
USD |
NASDAQ |
Sep 17, 16:00
4.15
+0.02
(+0.48%)
After-Hours: 20:00
LENZ Therapeutics Total Return Level : 4.403 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 4.403 |
| September 15, 2026 | 4.499 |
| September 14, 2026 | 4.754 |
| September 11, 2026 | 4.807 |
| September 10, 2026 | 5.020 |
| September 09, 2026 | 5.222 |
| September 08, 2026 | 5.669 |
| September 04, 2026 | 6.339 |
| September 03, 2026 | 6.201 |
| September 02, 2026 | 6.169 |
| September 01, 2026 | 5.562 |
| August 31, 2026 | 5.541 |
| August 28, 2026 | 5.435 |
| August 27, 2026 | 5.116 |
| August 26, 2026 | 5.084 |
| August 25, 2026 | 4.967 |
| August 24, 2026 | 4.882 |
| August 21, 2026 | 4.978 |
| August 20, 2026 | 4.956 |
| August 19, 2026 | 5.233 |
| August 18, 2026 | 5.073 |
| August 17, 2026 | 5.094 |
| August 14, 2026 | 5.031 |
| August 13, 2026 | 4.892 |
| August 12, 2026 | 5.360 |
| Date | Value |
|---|---|
| August 11, 2026 | 5.541 |
| August 10, 2026 | 5.701 |
| August 07, 2026 | 5.701 |
| August 06, 2026 | 5.552 |
| August 05, 2026 | 5.605 |
| August 04, 2026 | 5.371 |
| August 03, 2026 | 5.313 |
| July 31, 2026 | 5.637 |
| July 30, 2026 | 6.126 |
| July 29, 2026 | 6.084 |
| July 28, 2026 | 6.254 |
| July 27, 2026 | 6.062 |
| July 24, 2026 | 5.828 |
| July 23, 2026 | 5.371 |
| July 22, 2026 | 5.680 |
| July 21, 2026 | 5.488 |
| July 20, 2026 | 5.275 |
| July 17, 2026 | 5.509 |
| July 16, 2026 | 5.190 |
| July 15, 2026 | 5.307 |
| July 14, 2026 | 5.244 |
| July 13, 2026 | 5.562 |
| July 10, 2026 | 5.945 |
| July 09, 2026 | 6.158 |
| July 08, 2026 | 6.520 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Impact BioMedical, Inc. | 0.498 |
| Enveric Biosciences, Inc. | 1.49 |
| Ocular Therapeutix, Inc. | 9.87 |
| Liquidia Corp. | 68.45 |
| Aquestive Therapeutics, Inc. | 4.82 |